Compare IRS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | ALVO |
|---|---|---|
| Founded | 1943 | 2013 |
| Country | Argentina | Luxembourg |
| Employees | 1392 | 1032 |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | IRS | ALVO |
|---|---|---|
| Price | $15.91 | $3.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 203.7K | ★ 645.6K |
| Earning Date | 05-05-2026 | 03-18-2026 |
| Dividend Yield | ★ 9.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.82 |
| Revenue Next Year | N/A | $25.80 |
| P/E Ratio | ★ $3.66 | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.61 | $3.03 |
| 52 Week High | $19.14 | $11.85 |
| Indicator | IRS | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 41.37 |
| Support Level | $15.81 | $3.03 |
| Resistance Level | $16.37 | $4.17 |
| Average True Range (ATR) | 0.77 | 0.20 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 86.36 | 47.65 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.